NCT00147563View on ClinicalTrials.gov

Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

May 31, 2006

Conditions
Hypertension
Interventions
DRUG

Eplerenone

Trial Locations (1)

H2W 1R7

Pfizer Investigational Site, Montreal

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY